Persistent cough that lasts beyond two weeks should not be ignored. It can be signs of chronic bronchitis, tuberculosis, ...

The FDA approved Hernexeos for adults with unresectable or metastatic non-squamous non-small cell lung cancer.

Approval followed priority review and was based on response rates and duration of response demonstrated in the phase 1b ...

Rheumatoid arthritis (RA) commonly causes joint damage and fatigue, but it may sometimes cause symptoms that affect your skin ...

Patients with bronchiectasis–RA overlap syndrome (BROS) had a 2.09-fold higher mortality risk compared to those with ...

GlaxoSmithKline plc (UK) (($GB:GSK)) announced an update on their ongoing clinical study. GlaxoSmithKline (GSK) is ...

Discover Trevi Therapeutics' Q2 2025 progress, featuring groundbreaking CORAL & RIVER trial data, a $204M cash position, and plans for multiple Phase ...

Individuals with vs. without interstitial lung disease faced an elevated risk for lung cancer and histological subtypes of lung cancer in adjusted and sibling-controlled analyses, according to results ...

The U.S. Food and Drug Administration said on Friday it has approved Boehringer Ingelheim's drug for patients with a type of ...

Objectives With the growing adoption of virtual consultations in primary care, the need for tailored metrics to evaluate their safety became increasingly urgent. This systematic review seeks to ...

Mild and moderate infections are common among individuals with IBD and tend to be linked to patient characteristics and treatments.

The FDA has granted accelerated approval to zongertinib for pretreated, HER2+ non-squamous NSC lung cancer, based on results ...